Home › Type 1 Diabetes › NCT06931275
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Who can join
Ages 2 to 95 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Age ≥ 2 years with an EMR diagnosis of T1D for at least 6 months at baseline and receiving care at one of six intervention centers or a matched control at another T1DX-QI center. Inclusion Criteria: * non-Hispanic Black and Hispanic individuals Exclusion Criteria: * PwT1D with evidence of use of AID at baseline
About the study
The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions.
The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA).
The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies.
Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.
What is being tested
- EMR-based BPA model (other)
- Placebo (EMR-based without BPA model) (behavioral)
Sponsor: T1D Exchange, United States · Participants: 1,178 · Started: Aug 13, 2024
Contact the study team
- Osagie Ebekozien, MD · Phone: 857-205-2388
- Trevon Wright, MHA · Phone: 6178927564
Official record on ClinicalTrials.gov — NCT06931275
Locations in the U.S.
| Massachusetts | T1D Exchange, Boston T1D Exchange, Boston (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.